المؤلفون: Xu K; Department of Haematology, University College London Hospitals NHS Foundation Trust, University College London, London, UK.; Specialist Integrated Haematology Malignancy Diagnostic Service, Health Services Laboratories, University College London Hospitals NHS Foundation Trust, University College London, London, UK., Childerhouse A; Specialist Integrated Haematology Malignancy Diagnostic Service, Health Services Laboratories, University College London Hospitals NHS Foundation Trust, University College London, London, UK.; Department of Histopathology, University College London Hospitals NHS Foundation Trust, University College London, London, UK., Gupta R; Department of Haematology, University College London Hospitals NHS Foundation Trust, University College London, London, UK.; Specialist Integrated Haematology Malignancy Diagnostic Service, Health Services Laboratories, University College London Hospitals NHS Foundation Trust, University College London, London, UK.

المصدر: International journal of laboratory hematology [Int J Lab Hematol] 2024 Apr; Vol. 46 (2), pp. 212-213. Date of Electronic Publication: 2023 Sep 18.

نوع المنشور: Case Reports

بيانات الدورية: Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 101300213 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1751-553X (Electronic) Linking ISSN: 17515521 NLM ISO Abbreviation: Int J Lab Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Mast-Cell*/diagnosis , Leukemia, Mast-Cell*/genetics , Myelodysplastic Syndromes*/diagnosis , Myelodysplastic Syndromes*/genetics, Humans ; Mutation ; Proto-Oncogene Proteins c-kit/genetics ; Mast Cells

المؤلفون: Hamilton MJ; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. mjhamilton@bwh.harvard.edu.

المصدر: Current gastroenterology reports [Curr Gastroenterol Rep] 2024 Apr; Vol. 26 (4), pp. 107-114. Date of Electronic Publication: 2024 Feb 14.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Current Science Inc Country of Publication: United States NLM ID: 100888896 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-312X (Electronic) Linking ISSN: 15228037 NLM ISO Abbreviation: Curr Gastroenterol Rep Subsets: MEDLINE

مواضيع طبية MeSH: Mastocytosis*/complications , Mastocytosis*/diagnosis , Mastocytosis*/therapy , Mast Cell Activation Syndrome* , Irritable Bowel Syndrome*/complications , Irritable Bowel Syndrome*/diagnosis , Irritable Bowel Syndrome*/therapy , Gastrointestinal Diseases*/diagnosis , Gastrointestinal Diseases*/etiology , Gastrointestinal Diseases*/therapy, Humans ; Mast Cells/pathology

المؤلفون: Zaghmout T; Department of Respiratory Medicine and Allergy, Karolinska University Hospital Huddinge, Stockholm, Sweden; Department of Medicine Solna, Division of Clinical Immunology and Allergy, Karolinska Institutet, Stockholm, Sweden., Maclachlan L; Department of Respiratory Medicine and Allergy, Karolinska University Hospital Huddinge, Stockholm, Sweden; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden., Bedi N; Department of Respiratory Medicine and Allergy, Karolinska University Hospital Huddinge, Stockholm, Sweden., Gülen T; Department of Respiratory Medicine and Allergy, Karolinska University Hospital Huddinge, Stockholm, Sweden; Department of Medicine Solna, Division of Clinical Immunology and Allergy, Karolinska Institutet, Stockholm, Sweden; Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden; Mastocytosis Center Karolinska, Karolinska University Hospital, Stockholm, Sweden. Electronic address: theo.gulen@regionstockholm.se.

المصدر: The journal of allergy and clinical immunology. In practice [J Allergy Clin Immunol Pract] 2024 Mar; Vol. 12 (3), pp. 753-761. Date of Electronic Publication: 2023 Dec 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101597220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-2201 (Electronic) NLM ISO Abbreviation: J Allergy Clin Immunol Pract Subsets: MEDLINE

مواضيع طبية MeSH: Mast Cell Activation Syndrome* , Mastocytosis*/diagnosis , Mastocytosis*/epidemiology , Hypersensitivity* , Anaphylaxis*/diagnosis, Humans ; Adolescent ; Adult ; Mast Cells ; Tryptases ; Retrospective Studies ; Prevalence ; Delayed Diagnosis

المؤلفون: Gulen T; Department of Respiratory Medicine and Allergy, K85, Karolinska University Hospital Huddinge, Stockholm, SE-14186, Sweden. theo.gulen@ki.se.; Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden. theo.gulen@ki.se.; Clinical Lung and Allergy Research Unit, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden. theo.gulen@ki.se.; Mastocytosis Centre Karolinska, Karolinska University Hospital Huddinge, Stockholm, Sweden. theo.gulen@ki.se.

المصدر: Current allergy and asthma reports [Curr Allergy Asthma Rep] 2024 Feb; Vol. 24 (2), pp. 39-51. Date of Electronic Publication: 2024 Jan 20.

نوع المنشور: Journal Article; Review; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Current Science Inc Country of Publication: United States NLM ID: 101096440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-6315 (Electronic) Linking ISSN: 15297322 NLM ISO Abbreviation: Curr Allergy Asthma Rep Subsets: MEDLINE

مواضيع طبية MeSH: Mastocytosis* , Mast Cell Activation Syndrome*, Humans ; Tryptases ; Mast Cells ; Diagnosis, Differential

المؤلفون: Sabato V; Department of Immunology, Allergology, Rheumatology, The Infla-Med Centre of Excellence, Faculty of Medicine and Health Sciences, University of Antwerp, Campus Drie Eiken T5.9582 Universiteitsplein 1, 2610, Antwerp, Belgium.; Antwerp University Hospital, Edegem, Belgium., Beyens M; Department of Immunology, Allergology, Rheumatology, The Infla-Med Centre of Excellence, Faculty of Medicine and Health Sciences, University of Antwerp, Campus Drie Eiken T5.9582 Universiteitsplein 1, 2610, Antwerp, Belgium.; Antwerp University Hospital, Edegem, Belgium., Toscano A; Department of Immunology, Allergology, Rheumatology, The Infla-Med Centre of Excellence, Faculty of Medicine and Health Sciences, University of Antwerp, Campus Drie Eiken T5.9582 Universiteitsplein 1, 2610, Antwerp, Belgium.; Antwerp University Hospital, Edegem, Belgium., Van Gasse A; Department of Paediatrics, The Infla-Med Centre of Excellence, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium., Ebo DG; Department of Immunology, Allergology, Rheumatology, The Infla-Med Centre of Excellence, Faculty of Medicine and Health Sciences, University of Antwerp, Campus Drie Eiken T5.9582 Universiteitsplein 1, 2610, Antwerp, Belgium. immuno@uantwerpen.be.; Antwerp University Hospital, Edegem, Belgium. immuno@uantwerpen.be.

المصدر: Current allergy and asthma reports [Curr Allergy Asthma Rep] 2024 Feb; Vol. 24 (2), pp. 63-71. Date of Electronic Publication: 2024 Jan 13.

نوع المنشور: Journal Article; Review; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Current Science Inc Country of Publication: United States NLM ID: 101096440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-6315 (Electronic) Linking ISSN: 15297322 NLM ISO Abbreviation: Curr Allergy Asthma Rep Subsets: MEDLINE

مواضيع طبية MeSH: Mast Cell Activation Syndrome* , Mastocytosis, Systemic*/drug therapy , Mastocytosis, Systemic*/metabolism , Anaphylaxis*/drug therapy , Mastocytosis*/drug therapy, Humans ; Mast Cells ; Prospective Studies

المؤلفون: McLornan DP; Chair of the Chronic Malignancies Working Party of the EBMT. Department of Haematology and Stem Cell Transplantation, University College Hospital, London, UK. donal.mclornan@nhs.net., Czerw T; Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice, Poland., Damaj G; Haematology Institute, Normandy University School of Medicine, Caen, France., Ethell M; Department of Haematology, The Royal Marsden NHS Hospital, Sutton, UK., Gurnari C; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Hernández-Boluda JC; Hospital Clínico Universitario-INCLIVA, University of Valencia, Valencia, Spain., Polverelli N; Unit of Bone Marrow Transplantation, Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Schwaab J; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany., Sockel K; Medical Clinic and Policlinic I, University Hospital Dresden, TU Dresden, Germany., Raffaella G; Co-Chair of the Practice Harmonization and Guidelines Committee of EBMT and Chair of the ADWP of the EBMT. Haematology and Bone Marrow Transplant Unit, IRCCS San Raffaele Hospital, Milano, Italy., Onida F; Co-Chair of the Practice Harmonization and Guidelines Committee of the EBMT. ASST Fatebenefratelli-Sacco-University of Milan, Milano, Italy., Sánchez-Ortega I; Secretary of the Practice Harmonization and Guidelines Committee of EBMT, EBMT Medical Officer, Executive Office, Barcelona, Spain., Battipaglia G; Hematology Department, Federico II University of Naples, Naples, Italy., Elena C; Department of Hematology Oncology, Foundation IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy., Gotlib J; Division of Hematology, Stanford Cancer Institute/Stanford University School of Medicine, Stanford, CA, USA., Reiter A; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany., Rossignol J; Center National de Référence des Mastocytoses (CEREMAST), Service d'hématologie adulte, Hôpitaux Necker-Enfants Malades et Cochin, Paris, France., Ustun C; Division of Hematology/Oncology/Cell Therapy, Rush University, Chicago, IL, USA., Valent P; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.; Director of the Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.; Coordinator of the European Competence Network on Mastocytosis (ECNM), Vienna, Austria., Yakoub-Agha I; Chair of the EBMT Practice Harmonization and Guidelines Committee. CHU de Lille, Univ Lille, INSERM U1286, Infinite, 59000, Lille, France., Radia DH; Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London, UK.

المصدر: Leukemia [Leukemia] 2024 Apr; Vol. 38 (4), pp. 699-711. Date of Electronic Publication: 2024 Mar 12.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

مواضيع طبية MeSH: Mastocytosis, Systemic*/therapy , Mastocytosis, Systemic*/drug therapy , Antineoplastic Agents*/therapeutic use , Mastocytosis*/therapy , Leukemia, Mast-Cell*/drug therapy , Hematopoietic Stem Cell Transplantation*, Humans ; Proto-Oncogene Proteins c-kit/genetics ; Mast Cells

المؤلفون: Shin H; Division of Allergy & Immunology, Department of Medicine, University of California San Diego, La Jolla, CA, USA., Lyons JJ; Division of Allergy & Immunology, Department of Medicine, University of California San Diego, La Jolla, CA, USA. j3lyons@ucsd.edu.; Veterans Affairs San Diego Healthcare System, La Jolla, CA, USA. j3lyons@ucsd.edu.

المصدر: Current allergy and asthma reports [Curr Allergy Asthma Rep] 2024 Apr; Vol. 24 (4), pp. 199-209. Date of Electronic Publication: 2024 Mar 09.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Current Science Inc Country of Publication: United States NLM ID: 101096440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-6315 (Electronic) Linking ISSN: 15297322 NLM ISO Abbreviation: Curr Allergy Asthma Rep Subsets: MEDLINE

مواضيع طبية MeSH: Anaphylaxis*/genetics , Anaphylaxis*/diagnosis , Mastocytosis*/genetics , Mastocytosis*/diagnosis , Mast Cell Activation Syndrome*, Humans ; Mast Cells ; Tryptases/genetics ; Retrospective Studies ; Prospective Studies

SCR Disease Name: Hereditary alpha-tryptasemia syndrome

المؤلفون: Oka M; Laboratory of Pharmacology, Division of Pathological Sciences (M.O., M.T., Y.H.-T., S.T.), Bioscience Research Center (M.S.), and Laboratory of Pharmacology and Experimental Therapeutics, Division of Pathological Sciences (S.K.), Kyoto Pharmaceutical University, Kyoto, Japan; Division of Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan (S.A., K.F.); Laboratory of Medicinal Chemistry, Department of Chemistry and Life Science, School of Advanced Engineering, Kogakuin University, Tokyo, Japan (O.O.); Department of Molecular and Cellular Biochemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan (A.I.); Department of Health Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan (J.A.); and Department of Pharmacy, Faculty of Pharmacy, Yasuda Women's University, Hiroshima, Japan (K.M.)., Akaki S; Laboratory of Pharmacology, Division of Pathological Sciences (M.O., M.T., Y.H.-T., S.T.), Bioscience Research Center (M.S.), and Laboratory of Pharmacology and Experimental Therapeutics, Division of Pathological Sciences (S.K.), Kyoto Pharmaceutical University, Kyoto, Japan; Division of Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan (S.A., K.F.); Laboratory of Medicinal Chemistry, Department of Chemistry and Life Science, School of Advanced Engineering, Kogakuin University, Tokyo, Japan (O.O.); Department of Molecular and Cellular Biochemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan (A.I.); Department of Health Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan (J.A.); and Department of Pharmacy, Faculty of Pharmacy, Yasuda Women's University, Hiroshima, Japan (K.M.)., Ohno O; Laboratory of Pharmacology, Division of Pathological Sciences (M.O., M.T., Y.H.-T., S.T.), Bioscience Research Center (M.S.), and Laboratory of Pharmacology and Experimental Therapeutics, Division of Pathological Sciences (S.K.), Kyoto Pharmaceutical University, Kyoto, Japan; Division of Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan (S.A., K.F.); Laboratory of Medicinal Chemistry, Department of Chemistry and Life Science, School of Advanced Engineering, Kogakuin University, Tokyo, Japan (O.O.); Department of Molecular and Cellular Biochemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan (A.I.); Department of Health Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan (J.A.); and Department of Pharmacy, Faculty of Pharmacy, Yasuda Women's University, Hiroshima, Japan (K.M.)., Terasaki M; Laboratory of Pharmacology, Division of Pathological Sciences (M.O., M.T., Y.H.-T., S.T.), Bioscience Research Center (M.S.), and Laboratory of Pharmacology and Experimental Therapeutics, Division of Pathological Sciences (S.K.), Kyoto Pharmaceutical University, Kyoto, Japan; Division of Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan (S.A., K.F.); Laboratory of Medicinal Chemistry, Department of Chemistry and Life Science, School of Advanced Engineering, Kogakuin University, Tokyo, Japan (O.O.); Department of Molecular and Cellular Biochemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan (A.I.); Department of Health Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan (J.A.); and Department of Pharmacy, Faculty of Pharmacy, Yasuda Women's University, Hiroshima, Japan (K.M.)., Hamaoka-Tamura Y; Laboratory of Pharmacology, Division of Pathological Sciences (M.O., M.T., Y.H.-T., S.T.), Bioscience Research Center (M.S.), and Laboratory of Pharmacology and Experimental Therapeutics, Division of Pathological Sciences (S.K.), Kyoto Pharmaceutical University, Kyoto, Japan; Division of Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan (S.A., K.F.); Laboratory of Medicinal Chemistry, Department of Chemistry and Life Science, School of Advanced Engineering, Kogakuin University, Tokyo, Japan (O.O.); Department of Molecular and Cellular Biochemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan (A.I.); Department of Health Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan (J.A.); and Department of Pharmacy, Faculty of Pharmacy, Yasuda Women's University, Hiroshima, Japan (K.M.)., Saito M; Laboratory of Pharmacology, Division of Pathological Sciences (M.O., M.T., Y.H.-T., S.T.), Bioscience Research Center (M.S.), and Laboratory of Pharmacology and Experimental Therapeutics, Division of Pathological Sciences (S.K.), Kyoto Pharmaceutical University, Kyoto, Japan; Division of Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan (S.A., K.F.); Laboratory of Medicinal Chemistry, Department of Chemistry and Life Science, School of Advanced Engineering, Kogakuin University, Tokyo, Japan (O.O.); Department of Molecular and Cellular Biochemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan (A.I.); Department of Health Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan (J.A.); and Department of Pharmacy, Faculty of Pharmacy, Yasuda Women's University, Hiroshima, Japan (K.M.)., Kato S; Laboratory of Pharmacology, Division of Pathological Sciences (M.O., M.T., Y.H.-T., S.T.), Bioscience Research Center (M.S.), and Laboratory of Pharmacology and Experimental Therapeutics, Division of Pathological Sciences (S.K.), Kyoto Pharmaceutical University, Kyoto, Japan; Division of Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan (S.A., K.F.); Laboratory of Medicinal Chemistry, Department of Chemistry and Life Science, School of Advanced Engineering, Kogakuin University, Tokyo, Japan (O.O.); Department of Molecular and Cellular Biochemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan (A.I.); Department of Health Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan (J.A.); and Department of Pharmacy, Faculty of Pharmacy, Yasuda Women's University, Hiroshima, Japan (K.M.)., Inoue A; Laboratory of Pharmacology, Division of Pathological Sciences (M.O., M.T., Y.H.-T., S.T.), Bioscience Research Center (M.S.), and Laboratory of Pharmacology and Experimental Therapeutics, Division of Pathological Sciences (S.K.), Kyoto Pharmaceutical University, Kyoto, Japan; Division of Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan (S.A., K.F.); Laboratory of Medicinal Chemistry, Department of Chemistry and Life Science, School of Advanced Engineering, Kogakuin University, Tokyo, Japan (O.O.); Department of Molecular and Cellular Biochemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan (A.I.); Department of Health Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan (J.A.); and Department of Pharmacy, Faculty of Pharmacy, Yasuda Women's University, Hiroshima, Japan (K.M.)., Aoki J; Laboratory of Pharmacology, Division of Pathological Sciences (M.O., M.T., Y.H.-T., S.T.), Bioscience Research Center (M.S.), and Laboratory of Pharmacology and Experimental Therapeutics, Division of Pathological Sciences (S.K.), Kyoto Pharmaceutical University, Kyoto, Japan; Division of Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan (S.A., K.F.); Laboratory of Medicinal Chemistry, Department of Chemistry and Life Science, School of Advanced Engineering, Kogakuin University, Tokyo, Japan (O.O.); Department of Molecular and Cellular Biochemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan (A.I.); Department of Health Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan (J.A.); and Department of Pharmacy, Faculty of Pharmacy, Yasuda Women's University, Hiroshima, Japan (K.M.)., Matsuno K; Laboratory of Pharmacology, Division of Pathological Sciences (M.O., M.T., Y.H.-T., S.T.), Bioscience Research Center (M.S.), and Laboratory of Pharmacology and Experimental Therapeutics, Division of Pathological Sciences (S.K.), Kyoto Pharmaceutical University, Kyoto, Japan; Division of Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan (S.A., K.F.); Laboratory of Medicinal Chemistry, Department of Chemistry and Life Science, School of Advanced Engineering, Kogakuin University, Tokyo, Japan (O.O.); Department of Molecular and Cellular Biochemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan (A.I.); Department of Health Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan (J.A.); and Department of Pharmacy, Faculty of Pharmacy, Yasuda Women's University, Hiroshima, Japan (K.M.)., Furuta K; Laboratory of Pharmacology, Division of Pathological Sciences (M.O., M.T., Y.H.-T., S.T.), Bioscience Research Center (M.S.), and Laboratory of Pharmacology and Experimental Therapeutics, Division of Pathological Sciences (S.K.), Kyoto Pharmaceutical University, Kyoto, Japan; Division of Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan (S.A., K.F.); Laboratory of Medicinal Chemistry, Department of Chemistry and Life Science, School of Advanced Engineering, Kogakuin University, Tokyo, Japan (O.O.); Department of Molecular and Cellular Biochemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan (A.I.); Department of Health Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan (J.A.); and Department of Pharmacy, Faculty of Pharmacy, Yasuda Women's University, Hiroshima, Japan (K.M.)., Tanaka S; Laboratory of Pharmacology, Division of Pathological Sciences (M.O., M.T., Y.H.-T., S.T.), Bioscience Research Center (M.S.), and Laboratory of Pharmacology and Experimental Therapeutics, Division of Pathological Sciences (S.K.), Kyoto Pharmaceutical University, Kyoto, Japan; Division of Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan (S.A., K.F.); Laboratory of Medicinal Chemistry, Department of Chemistry and Life Science, School of Advanced Engineering, Kogakuin University, Tokyo, Japan (O.O.); Department of Molecular and Cellular Biochemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan (A.I.); Department of Health Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan (J.A.); and Department of Pharmacy, Faculty of Pharmacy, Yasuda Women's University, Hiroshima, Japan (K.M.) s@mb.kyoto-phu.ac.jp.

المصدر: The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2024 Mar 15; Vol. 389 (1), pp. 76-86. Date of Electronic Publication: 2024 Mar 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society for Pharmacology and Experimental Therapeutics Country of Publication: United States NLM ID: 0376362 Publication Model: Electronic Cited Medium: Internet ISSN: 1521-0103 (Electronic) Linking ISSN: 00223565 NLM ISO Abbreviation: J Pharmacol Exp Ther Subsets: MEDLINE

مواضيع طبية MeSH: Cromolyn Sodium*/pharmacology , Mast Cell Stabilizers*/pharmacology, Rats ; Mice ; Animals ; Mast Cells ; Receptors, G-Protein-Coupled/metabolism ; Immunoglobulin E/metabolism ; Immunoglobulin E/pharmacology ; Cell Degranulation

المؤلفون: González-de-Olano D; Department of Allergy, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain.; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Salamanca, Spain., Navarro-Navarro P; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Salamanca, Spain.; Department of Medicine and Citometry Service (NUCLEUS), Cancer Research Center (IBMCC, USAL-CSIC), Universidad de Salamanca, Salamanca, Spain.; Sequencing Service (NUCLEUS), Universidad de Salamanca, Salamanca, Spain., Muñoz-González JI; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Salamanca, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain., Sánchez-Muñoz L; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Salamanca, Spain.; Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast), Virgen del Valle Hospital, Toledo, Spain., Henriques A; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Salamanca, Spain.; Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast), Virgen del Valle Hospital, Toledo, Spain., de-Andrés-Martín A; Department of Immunology, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain., Peralta-Arjonilla D; Department of Immunology, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain., Mayado A; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Salamanca, Spain.; Department of Medicine and Citometry Service (NUCLEUS), Cancer Research Center (IBMCC, USAL-CSIC), Universidad de Salamanca, Salamanca, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain., Jara-Acevedo M; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Salamanca, Spain.; Sequencing Service (NUCLEUS), Universidad de Salamanca, Salamanca, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain., García-Montero AC; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Salamanca, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain., Orfao A; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Salamanca, Spain.; Department of Medicine and Citometry Service (NUCLEUS), Cancer Research Center (IBMCC, USAL-CSIC), Universidad de Salamanca, Salamanca, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain., Álvarez-Twose I; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Salamanca, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain.; Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast), Virgen del Valle Hospital, Toledo, Spain.

المصدر: Allergy [Allergy] 2024 Mar; Vol. 79 (3), pp. 711-723. Date of Electronic Publication: 2023 Oct 11.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: Denmark NLM ID: 7804028 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1398-9995 (Electronic) Linking ISSN: 01054538 NLM ISO Abbreviation: Allergy Subsets: MEDLINE

مواضيع طبية MeSH: Anaphylaxis*/epidemiology , Anaphylaxis*/genetics , Anaphylaxis*/diagnosis , Mastocytosis*/diagnosis , Mastocytosis*/epidemiology , Mastocytosis*/genetics , Mast Cell Activation Syndrome*, Humans ; Mast Cells ; Tryptases/genetics ; Genotype

SCR Disease Name: Hereditary alpha-tryptasemia syndrome

المؤلفون: Akin C; Department of Medicine, Division of Allergy and Immunology, University of Michigan, Ann Arbor, Mich. Electronic address: cemakin@umich.edu.

المصدر: The journal of allergy and clinical immunology. In practice [J Allergy Clin Immunol Pract] 2024 Mar; Vol. 12 (3), pp. 762-763.

نوع المنشور: Editorial

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101597220 Publication Model: Print Cited Medium: Internet ISSN: 2213-2201 (Electronic) NLM ISO Abbreviation: J Allergy Clin Immunol Pract Subsets: MEDLINE

مواضيع طبية MeSH: Mast Cell Activation Syndrome* , Mastocytosis*/diagnosis, Humans ; Mast Cells